MDxHealth SA (MDXH)

NASDAQ: MDXH · USD

$0.19

-0.01 (-2.8%)· Recorded snapshot

Market cap	18.3M
Revenue (ttm)	114M
Net income (ttm)	-37.3M
EPS (ttm)	-$0.74
Shares out	95.4M
Volume	1,528,979
Beta	-518218.96

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 114M
Net income (ttm): -37.3M
EPS (ttm): -$0.74
Market cap: 18.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-16.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MDXH indicators

Market & fundamental data

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001872529
Company name	MDxHealth SA
Country	Belgium
Country code	US
CUSIP number	B5950S113
Earnings date	2026-11-12
Earnings time	amc
Employees	364
Employees change	52
Employees growth	16.67%
Enterprise value	$104.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Diagnostics & Research
IPO date	2021-11-04
Is primary listing	Yes
Is SPAC	No
ISIN number	BE0974461940
Last 10-K release date	2026-04-03
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2023-11-14
Last stock split type	Reverse
Market cap	$18.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.19
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	MDXH
Website	https://mdxhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-387.52%
EV/Sales	0.92x
FCF / EV yield	-5.75%
FCF yield	-33.26%
Forward EV/Sales	0.85x
Forward P/S	0.15x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/S ratio	0.16x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-18.82%
EBITDA margin	-13.09%
Gross margin	62.86%
Operating margin	-18.82%
Pretax margin	-33.33%
Profit margin	-32.74%
Profit per employee	$-102,574
Revenue per employee	$313,253
ROA	-9.83%
ROA (5Y)	-17.56%
ROCE	-22.66%
ROE (5Y)	-714.82%
ROIC	-16.91%
SBC / revenue	2.02%
Tax / revenue	-1.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	18.84%
Gross profit growth (Q)	1.83%
Gross profit growth 3Y	30.63%
Gross profit growth 5Y	52.91%
Net income growth years	3
Revenue growth	22.59%
Revenue growth (Q)	2.27%
Revenue growth (QoQ)	-0.65%
Revenue growth 10Y	17.5%
Revenue growth 3Y	27.13%
Revenue growth 5Y	42.64%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-718,000
Depreciation and amortization	$6.5M
EBIT	$-21.5M
EBITDA	$-14.9M
EPS	$-0.74
FCF per share	$-0.06
Financing cash flow	$-1.2M
Free cash flow	$-6M
Free cash flow minus SBC	$-8.3M
Gross profit	$71.7M
Income taxes	$-1.6M
Investing cash flow	$-7.1M
Net borrowing	$16.7M
Net cash flow	$-13.6M
Net income	$-37.3M
Operating cash flow minus SBC	$-7.6M
Operating income	$-21.5M
Revenue	$114M
Stock-based compensation	$2.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.57
Book value per share	$-0.59
Goodwill	$39.3M
Interest coverage	-1.66
Long-term assets	$89.1M
Long-term liabilities	$125.1M
Net cash (debt)	$-86.6M
Net cash / market cap	-478.9%
Piotroski F-Score	2
Property, plant and equipment	$11.9M
Shareholders' equity	$-30.4M
Tangible book value	$-106.4M
Tangible book value per share	$-2.07
Total assets	$132.1M
Total cash	$19.2M
Total debt	$105.8M
Total liabilities	$162.5M
WACC	-416,036.21%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.84
Current assets	$43M
Current liabilities	$37.4M
Current ratio	1.15
Inventory turnover	8.39
Net working capital	$-11.8M
Quick ratio	0.91
Working capital	$5.6M
Working capital turnover	12.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.74%
Dividend yield	0%
Shareholder yield	-13.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.92
1D price change	-2.84%
1M price change	-66.42%
1M total return	-66.42%
1W price change	-2.37%
1W total return	-2.37%
1Y price change	-96.04%
1Y return CAGR	-96.05%
1Y total return	-96.04%
20-day SMA	$0.42
200-day SMA	$1.56
3M price change	-54.59%
3M total return	-54.59%
3Y price change	-92.41%
3Y return CAGR	-57.65%
3Y total return	-92.41%
50-day SMA	$0.57
50-day SMA vs 200-day SMA	50under200
52-week high	$5.33
52-week high date	2025-10-28
52-week low	$0.17
52-week low date	2026-10-19
6M price change	-90.7%
6M total return	-90.7%
All-time high	$11.60
All-time high date	2021-11-08
All-time low	$0.00
All-time low date	2022-08-17
Average true range (ATR)	$0.05
Average volume	1.8M
Beta (1Y)	3.8
Beta (2Y)	2.21
Beta (5Y)	-518,218.96
Change from 52-week high	-96.41%
Change from 52-week low	11.93%
Change from all-time high	-98.36%
Change from all-time low	1,897,900%
Change from open	-4.25%
Day's gap	1.47%
Dollar volume	$292,647
High price	$0.20
Low price	$0.18
Monthly RSI	33.24
Open price	$0.20
Position in 52-week range	45.15%
Premarket change	-2.99%
Premarket close	$0.20
Premarket price	$0.19
Premarket volume	122.7K
Previous close	$0.20
Price vs 150-day SMA	-79.34%
Price vs 20-day SMA	-54.6%
Price vs 200-day SMA	-87.83%
Price vs 50-day SMA	-66.92%
Relative volume	0.85
Return from IPO price	-98.59%
RSI	24.14
Sharpe ratio	-1.69
Sortino ratio	-2.21
Volume	1.5M
Weekly RSI	25.34
YTD price change	-94.68%
YTD total return	-94.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	79M
Float percentage	82.77%
Shares change (QoQ)	0.5%
Shares change (YoY)	13.74%
Shares held by insiders	7.44%
Shares held by institutions	48.95%
Shares outstanding	95.4M
Short % of shares	1.62%
Short ratio	5.9 days

Deeper analysis on MDXH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MDXH report

Is a complete MDXH research report available?

No complete published report is available for MDxHealth SA (MDXH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MDxHealth SA (MDXH)

Price

Financial snapshot

Fair-value bridge

Latest news · MDXH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MDXH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MDXH

Frequently asked questions